ENGENE THERAPEUTICS INC
Q2 2026 13F Holders
Symbol
ENGN
CUSIP
29286X101
Type
Equity
Class
COM
Num filings
62
Total reported value, excl. options
$66.6 M
Compare 2026 Q2 to
2026 Q3
2026 Q1
Manager
Report Date
Value ($000)
Shares
Option Type